Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 20 studies | 63% ± 18% |
Insufficient scRNA-seq data for expression of CLEC4C at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
peripheral blood | 77% | 54.52 | 717 / 929 | 0% | 0 | 0 / 0 |
spleen | 62% | 8.41 | 150 / 241 | 0% | 0 | 0 / 0 |
lung | 26% | 2.25 | 148 / 578 | 9% | 0.16 | 104 / 1155 |
lymph node | 0% | 0 | 0 / 0 | 24% | 0.90 | 7 / 29 |
breast | 6% | 0.35 | 28 / 459 | 12% | 0.32 | 132 / 1118 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.21 | 6 / 45 |
skin | 4% | 0.27 | 78 / 1809 | 7% | 0.21 | 35 / 472 |
ovary | 9% | 1.24 | 17 / 180 | 1% | 0.01 | 3 / 430 |
thymus | 4% | 0.32 | 29 / 653 | 5% | 0.13 | 32 / 605 |
adipose | 7% | 0.43 | 84 / 1204 | 0% | 0 | 0 / 0 |
stomach | 3% | 0.13 | 10 / 359 | 4% | 0.06 | 11 / 286 |
esophagus | 2% | 0.10 | 28 / 1445 | 4% | 0.07 | 7 / 183 |
intestine | 3% | 0.22 | 33 / 966 | 1% | 0.03 | 6 / 527 |
liver | 3% | 0.14 | 7 / 226 | 0% | 0.00 | 1 / 406 |
kidney | 2% | 0.18 | 2 / 89 | 1% | 0.04 | 9 / 901 |
uterus | 1% | 0.06 | 2 / 170 | 2% | 0.03 | 8 / 459 |
heart | 3% | 0.14 | 22 / 861 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0.02 | 1 / 328 | 2% | 0.04 | 4 / 178 |
blood vessel | 3% | 0.16 | 34 / 1335 | 0% | 0 | 0 / 0 |
prostate | 1% | 0.09 | 3 / 245 | 1% | 0.02 | 5 / 502 |
adrenal gland | 0% | 0.02 | 1 / 258 | 2% | 0.03 | 4 / 230 |
bladder | 0% | 0 | 0 / 21 | 2% | 0.04 | 9 / 504 |
brain | 1% | 0.08 | 33 / 2642 | 0% | 0.01 | 1 / 705 |
muscle | 1% | 0.08 | 10 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002250 | Biological process | adaptive immune response |
GO_0061760 | Biological process | antifungal innate immune response |
GO_0030667 | Cellular component | secretory granule membrane |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0070821 | Cellular component | tertiary granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0101003 | Cellular component | ficolin-1-rich granule membrane |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | CLEC4C |
Protein name | C-type lectin domain family 4 member C (Blood dendritic cell antigen 2) (BDCA-2) (C-type lectin superfamily member 7) (Dendritic lectin) (CD antigen CD303) C-type lectin domain family 4 member C |
Synonyms | HECL DLEC UNQ9361/PRO34150 CLECSF11 CLECSF7 BDCA2 |
Description | FUNCTION: Lectin-type cell surface receptor which may play a role in antigen capturing by dendritic cells . Specifically recognizes non-sialylated galactose-terminated biantennary glycans containing the trisaccharide epitope Gal(beta1-3/4)GlcNAc(beta1-2)Man . Binds to serum IgG . Efficiently targets ligand into antigen-processing and peptide-loading compartments for presentation to T-cells . May mediate potent inhibition of induction of IFN-alpha/beta expression in plasmacytoid dendritic cells . May act as a signaling receptor that activates protein-tyrosine kinases and mobilizes intracellular calcium . . |
Accessions | H0YGB2 ENST00000540085.5 [Q8WTT0-2] ENST00000360345.8 [Q8WTT0-1] ENST00000354629.9 [Q8WTT0-2] ENST00000542353.5 [Q8WTT0-1] ENST00000537530.1 H0YFH6 ENST00000543765.1 Q8WTT0 |